Avian reovirus (ATCC® VR-2449)

Classification: Reoviridae, Reovirus  /  Product Format: freeze-dried

Permits and Restrictions

View Permits

Classification Reoviridae, Reovirus
Agent Avian reovirus
Strain 2177
Biosafety Level 2

Biosafety  classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Isolation
Commercially-reared chickens afflicted with inflammation of the hock joints
Product Format freeze-dried
Storage Conditions -70°C or colder
Effect on Host
Cytopathic effects (syncytium and giant cell formation) within 5 to 7 days
Recommended Host
chicken embryo fibroblasts
chicken embryo, yolk or embryo; chicken embryo fibroblasts
Growth Conditions
Temperature: 37°C
Incubation: 2-4 days
Cryopreservation
Storage temperature: -20C for lyophilized; -70C for frozen
Effect on Host
Cytopathic effects (syncytium and giant cell formation) within 5 to 7 days
Name of Depositor Univ. Delaware, Akzo Pharmaceuticals
U.S. Patent Number
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished.
Source
Commercially-reared chickens afflicted with inflammation of the hock joints
References

Rosenberger JK, et al. Reovirus strain 2177 and vaccine containing same. US Patent 5,525,342 dated Jun 11 1996

RosenbergerCharacterization of Reoviruses Associated with a runting Syndrome in Chickens.In: RosenbergerDisease Prevention and Control in Poultry Production, Aug. 31-Sep 2, 1983Sydney Australia1983.

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

Basic Documentation